Luca Rozzini1,2, Marta Zaffira Conti3, Maddalena Riva3, Anna Ceraso3, Salvatore Caratozzolo3, Marina Zanetti3, Alessandro Padovani3. 1. Department of Clinical and Experimental Sciences, University of Brescia, Piazzale Spedali Civili, 1, 25100, Brescia, Italy. lrozzini@iol.it. 2. Geriatric Research Group, Brescia, Italy. lrozzini@iol.it. 3. Department of Clinical and Experimental Sciences, University of Brescia, Piazzale Spedali Civili, 1, 25100, Brescia, Italy.
Abstract
BACKGROUND: Prior studies documented that several sleep disorders may coexist in patients affected by Mild Cognitive Impairment (MCI) and Alzheimer disease (AD), and have a strong bidirectional relationship with cognitive decline. AIM: To assess the self-reported sleep quality and daytime sleepiness among subjects affected by MCI and AD at early-stage and healthy controls, and to verify if sleep disturbances might be an indicator of specific cognitive deficits. METHODS: 139 patients (102 MCI, 37 AD) underwent comprehensive neuropsychological, functional, and behavioral assessment, which also included Epworth Sleepiness Scale (ESS) and Pittsburgh Sleep Quality Index (PSQI). 80 healthy elderly subjects were used as controls. MCI patients have been divided into Good Sleepers and Bad Sleepers, depending on their reported sleep quality (PSQI global score ≤5/>5). RESULTS: MCI patients experienced more subjective daytime sleepiness than AD matches. As for the subjective sleep quality among MCI patients, 54% of Bad Sleepers met diagnostic criteria for non-amnestic MCI; vice-versa, 73% of Good Sleepers were diagnosed with amnestic-MCI (p = 0.005), independently of depression and anxiety. CONCLUSIONS: MCI patients complain of daytime sleepiness and dysfunction more than AD patients; among MCI patients, Bad Sleepers appear mainly characterized by a non-amnestic cognitive profile.
BACKGROUND: Prior studies documented that several sleep disorders may coexist in patients affected by Mild Cognitive Impairment (MCI) and Alzheimer disease (AD), and have a strong bidirectional relationship with cognitive decline. AIM: To assess the self-reported sleep quality and daytime sleepiness among subjects affected by MCI and AD at early-stage and healthy controls, and to verify if sleep disturbances might be an indicator of specific cognitive deficits. METHODS: 139 patients (102 MCI, 37 AD) underwent comprehensive neuropsychological, functional, and behavioral assessment, which also included Epworth Sleepiness Scale (ESS) and Pittsburgh Sleep Quality Index (PSQI). 80 healthy elderly subjects were used as controls. MCI patients have been divided into Good Sleepers and Bad Sleepers, depending on their reported sleep quality (PSQI global score ≤5/>5). RESULTS: MCI patients experienced more subjective daytime sleepiness than AD matches. As for the subjective sleep quality among MCI patients, 54% of Bad Sleepers met diagnostic criteria for non-amnestic MCI; vice-versa, 73% of Good Sleepers were diagnosed with amnestic-MCI (p = 0.005), independently of depression and anxiety. CONCLUSIONS: MCI patients complain of daytime sleepiness and dysfunction more than ADpatients; among MCI patients, Bad Sleepers appear mainly characterized by a non-amnestic cognitive profile.
Authors: Glenna S Brewster; Karen B Hirschman; Barbara J Riegel; Alexandra L Hanlon; Liming Huang; Miranda V McPhillips; Katherine M Abbott; Mary D Naylor Journal: Geriatr Nurs Date: 2019-03-07 Impact factor: 2.361
Authors: Nicholas V Resciniti; Valerie Yelverton; Bezawit E Kase; Jiajia Zhang; Matthew C Lohman Journal: Int J Environ Res Public Health Date: 2021-01-05 Impact factor: 3.390
Authors: Bernhard Grässler; Milos Dordevic; Fabian Herold; Sabine Darius; Corinna Langhans; Nicole Halfpaap; Berit K Labott; Patrick Müller; Achraf Ammar; Beatrice Thielmann; Irina Böckelmann; Notger G Müller; Anita Hökelmann Journal: Int J Environ Res Public Health Date: 2021-12-17 Impact factor: 3.390
Authors: Prabha Siddarth; Kitikan Thana-Udom; Rashi Ojha; David Merrill; Joseph M Dzierzewski; Karen Miller; Gary W Small; Linda Ercoli Journal: Int Psychogeriatr Date: 2020-09-28 Impact factor: 7.191